Creating an Efficient Clinical Trial Build System Via the Clinical Trials Rapid Activation Consortium (CTRAC)
通过临床试验快速激活联盟 (CTRAC) 创建高效的临床试验构建系统
基本信息
- 批准号:10227589
- 负责人:
- 金额:$ 30万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse eventCancer CenterClinical TrialsComplexCustomDevelopmentElectronic Health RecordExpenditureFormulariesFutureGoalsIndividualInstitutionInvestigational TherapiesLaboratoriesLeadershipManualsMedication ErrorsMethodsModificationParticipantPatient CarePharmaceutical PreparationsPoliciesProceduresProcessProtocols documentationProviderResearchSiteSpecific qualifier valueStandardizationStructureSystemTestingTimeWorkarmcostmembernovelstandard of caresupport networktreatment planning
项目摘要
PROJECT SUMMARY/ABSTRACT
Standard-of-care electronic health records (EHR) treatment plans are constructed once prior to implementation
and support quality through standardization. By comparison, treatment-plan builds for clinical trials may support
as few as zero trial participants, must be built from the ground up for each new trial and at each added site,
and have treatment plans that often require configurations for novel medications, numerous ancillary
procedures, and research finance requirements. The current paradigm is costly, complex, and inefficient.
Representatives of five cancer centers agreed to be part of the project’s Clinical Trials Rapid Activation
Consortium (CTRAC). The project’s goal is to develop processes across multiple NCI-supported cancer
centers that will facilitate the development of single builds of EHR clinical-trial treatment plans that can be
deployed at multiple institutions in support of NCI-sponsored network studies. Members will investigate the
question: can a small consortium of clinical trials sites develop methods to standardize workflows, drug
formularies, drug administration procedures, and laboratory requirements leading to the creation of the
components for a standardized, electronic, clinical-trials build system? The specific aims are as follows: 1) To
identify the tasks currently performed by EHR investigational treatment plans (SOPs, policies, and workflows)
and to define differences among these SOPs at the individual member sites of the consortium; 2) To
standardize the processes within each task where possible and document differences that would require
modifications across sites; 3) To develop a master assessment of EHR treatment-plan modules that could be
reused to perform components of the same research protocol tasks at multiple sites while maintaining
compliance with the requirements of member organizations of the consortium; 4) To organize a leadership
structure for the consortium that will work with the NCI and an EHR provider to oversee this initiative to assure
that adequate progress is made toward the ultimate goal of creating a fully automated electronic clinical-trial
build system that will facilitate the activation of clinical trials across all NCI-supported networks; 5) To build
standardized electronic clinical-trial build modules that could undergo future pilot testing at each institution for
a specified group of NCI-sponsored clinical trials; and 6) To facilitate development of metrics for the new EHR
processes that can demonstrate whether more consistent patient care, reduced medication errors, and fewer
adverse events result from a standardized approach to clinical-trial build modules.
项目总结/摘要
标准医疗电子健康记录(EHR)治疗计划在实施前构建一次
通过标准化支持质量。相比之下,临床试验的治疗计划可能支持
少至零试验参与者,必须为每个新试验和每个增加的地点从头开始建立,
并且有治疗计划,通常需要配置新的药物,许多辅助药物,
程序和研究资金要求。目前的模式是昂贵的,复杂的,效率低下的。
五个癌症中心的代表同意参与该项目的临床试验快速激活
Consortium(CTRAC).该项目的目标是开发跨多种NCI支持的癌症的过程
这些中心将促进EHR临床试验治疗计划的单一构建的发展,
部署在多个机构,以支持国家癌症研究所赞助的网络研究。成员将调查
问:一个小型的临床试验机构联盟能否开发出标准化工作流程、药物
处方集、药物管理程序和实验室要求,导致创建
标准化的电子临床试验构建系统的组件?具体目标如下:(1)
确定EHR研究性治疗计划(SOP、政策和工作流程)当前执行的任务
并确定这些标准操作规程在联合体各成员地点之间的差异; 2)
在可能的情况下,标准化每个任务中的流程,并记录需要
3)制定EHR治疗计划模块的主评估,
重复使用,以在多个研究中心执行相同研究方案任务的组成部分,同时保持
符合联合体成员组织的要求; 4)组织领导
该联盟将与NCI和EHR提供商合作,监督这一举措,以确保
朝着创建全自动电子临床试验的最终目标取得了足够的进展
建立一个系统,促进在所有NCI支持的网络中启动临床试验; 5)建立
标准化的电子临床试验构建模块,可以在每个机构进行未来的试点测试,
指定的一组由国家癌症研究所赞助的临床试验;以及6)促进新EHR指标的制定
可以证明更一致的患者护理,减少用药错误,
不良事件是由临床试验构建模块的标准化方法引起的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN Terry ROSEN其他文献
STEVEN Terry ROSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN Terry ROSEN', 18)}}的其他基金
Novel targeted therapies for HPV-associated Non-AIDS-defining cancers (Biospecimens/Biocohort)
针对 HPV 相关非艾滋病定义癌症的新型靶向疗法(生物样本/生物队列)
- 批准号:
10620083 - 财政年份:2022
- 资助金额:
$ 30万 - 项目类别:
Genomic and Microenvironment Analysis of HIV-Associated Diffuse Large B-cell Lymphoma (Immuno/Microenvironment)
HIV 相关弥漫性大 B 细胞淋巴瘤的基因组和微环境分析(免疫/微环境)
- 批准号:
10620074 - 财政年份:2022
- 资助金额:
$ 30万 - 项目类别:
Caribbean Investigation of Cancer Stigma and its effect on Cervical Cancer Screening and HPV Vaccination
加勒比癌症耻辱调查及其对宫颈癌筛查和 HPV 疫苗接种的影响
- 批准号:
10406126 - 财政年份:2021
- 资助金额:
$ 30万 - 项目类别:
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
靶向 p38 γ 信号传导以推进皮肤 T 细胞淋巴瘤治疗
- 批准号:
10525229 - 财政年份:2018
- 资助金额:
$ 30万 - 项目类别:
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
靶向 p38 γ 信号传导以推进皮肤 T 细胞淋巴瘤治疗
- 批准号:
10057371 - 财政年份:2018
- 资助金额:
$ 30万 - 项目类别:
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
靶向 p38 γ 信号传导以推进皮肤 T 细胞淋巴瘤治疗
- 批准号:
10296667 - 财政年份:2018
- 资助金额:
$ 30万 - 项目类别:
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
治疗急性髓系白血病的新型 RNA 导向疗法
- 批准号:
9243226 - 财政年份:2016
- 资助金额:
$ 30万 - 项目类别:
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
治疗急性髓系白血病的新型 RNA 导向疗法
- 批准号:
9107212 - 财政年份:2016
- 资助金额:
$ 30万 - 项目类别:
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
治疗急性髓系白血病的新型 RNA 导向疗法
- 批准号:
9900748 - 财政年份:2016
- 资助金额:
$ 30万 - 项目类别:
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
治疗急性髓系白血病的新型 RNA 导向疗法
- 批准号:
9458707 - 财政年份:2016
- 资助金额:
$ 30万 - 项目类别:
相似海外基金
Clinician Scientist Supporting NCI-funded Clinical Trials at the Medical College of Wisconsin Cancer Center
临床科学家在威斯康星医学院癌症中心支持 NCI 资助的临床试验
- 批准号:
10561882 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Admin. Supp. for NCI P30 Cancer Center Grants to Facilitate the Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites
行政。
- 批准号:
10442122 - 财政年份:2021
- 资助金额:
$ 30万 - 项目类别:
Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials at the University of Iowa Holden Comprehensive Cancer Center
为爱荷华大学霍尔顿综合癌症中心 NCI 支持的临床试验制定标准化电子治疗计划
- 批准号:
10439980 - 财政年份:2021
- 资助金额:
$ 30万 - 项目类别:
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)
Dana-Farber/哈佛大学癌症中心实验治疗临床试验网络网站(DF/HCC ETCTN 网站)
- 批准号:
10784840 - 财政年份:2014
- 资助金额:
$ 30万 - 项目类别:
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site) - Incorporation of Mayo Clinic Cancer Center as an Affiliated Center
Dana-Farber/哈佛大学癌症中心实验治疗临床试验网络网站(DF/HCC ETCTN 网站)- 梅奥诊所癌症中心并入附属中心
- 批准号:
10393266 - 财政年份:2014
- 资助金额:
$ 30万 - 项目类别:
Cancer Center Model For Early Phase Clinical Trials
早期临床试验的癌症中心模型
- 批准号:
6666180 - 财政年份:2003
- 资助金额:
$ 30万 - 项目类别:
Cancer Center Model For Early Phase Clinical Trials
早期临床试验的癌症中心模型
- 批准号:
6794174 - 财政年份:2003
- 资助金额:
$ 30万 - 项目类别:
Cancer Center Model For Early Phase Clinical Trials
早期临床试验的癌症中心模型
- 批准号:
7124526 - 财政年份:2003
- 资助金额:
$ 30万 - 项目类别:
Cancer Center Support Grant - Clinical Trials Reporting Supplement (CTRP)
癌症中心支持补助金 - 临床试验报告补充材料 (CTRP)
- 批准号:
8138132 - 财政年份:1997
- 资助金额:
$ 30万 - 项目类别:
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
癌症中心临床试验报告计划 (CTRP) 早期采用者
- 批准号:
7923465 - 财政年份:1997
- 资助金额:
$ 30万 - 项目类别: